New model could help provide expectant mothers a clearer path to safe fish consumption
For immediate release: June 28, 2024
Boston, MA—Fish consumption during pregnancy is a complex scientific topic. On one hand, fish are rich in nutrients essential to brain development, including polyunsaturated fatty acids, selenium, iodine, and vitamin D. On the other, fish contain methyl mercury, a known neurotoxicant. This has led the U.S. Food and Drug Administration to recommend that expectant mothers limit consumption, which inadvertently causes many women to forgo fish consumption during pregnancy altogether.
Fish consumption is an important route of methyl mercury exposure, however, efforts to understand the health risk posed by mercury are further complicated by the fact that the nutritional benefits from fish may modify or reduce the toxicity posed by mercury. A new study appearing in the American Journal of Epidemiology based on data from a cohort of residents of a coastal community in Massachusetts creates a new framework that could untangle these questions, reduce confusion, and produce clearer guidance on fish consumption for pregnant mothers.
“We propose an alternative modelling approach to address limitations of previous models and to contribute thereby to improved evidence-based advice on the risks and benefits of fish consumption,” said the authors, who include Sally Thurston, with the University of Rochester Medical Center; Susan Korrick, with Harvard T.H. Chan School of Public Health and Brigham and Women’s Hospital; and David Ruppert, with Cornell University. “In fish-eating populations, this can be addressed by separating mercury exposure into fish intake and average mercury content of the consumed fish.”
The new research comes from an analysis of data from the New Bedford Cohort, which was created to assess the health of children born to mothers residing near the New Bedford Harbor Superfund site in Massachusetts. The current study included 361 children from the cohort who were born between 1993 and 1998 and underwent neurodevelopment assessments, including tests for IQ, language, memory, and attention, at age eight years.
The researchers were able to measure mercury exposure during the third trimester of pregnancy through hair samples collected from the mothers after birth. While hair samples have been the traditional method to study maternal mercury exposure, this approach alone cannot distinguish between mothers who frequently consumed low-mercury fish compared to those who consumed a smaller quantity of high-mercury fish.
To overcome this limitation, the researchers instead created a model that includes estimates of mercury exposure per serving of fish. This was possible because mothers in the cohort also completed a food questionnaire and reported the type and frequency of fish and shellfish consumed during pregnancy. The authors estimated the average mercury levels by type of fish, and when combined with the information about the mother’s diet, they were able to create a more precise and detailed method to estimate the joint associations of pregnancy fish intake and fish mercury levels on neurodevelopment.
Using this model, the researchers found that the relation between pregnancy fish consumption and subsequent neurodevelopment varied depending on the estimated average mercury levels in the fish. Specifically, consuming low mercury-containing fish was beneficial, while consuming fish with higher levels of mercury was detrimental.
“Given methodologic limitations to previous analyses, future work expanding our alternative modelling approach to account for both the average mercury and nutritional content of fish could facilitate better estimation of the risk-benefit tradeoffs of fish consumption, a key component of many healthy diets,” said the authors.
The authors are in the process of applying this model to other large studies of maternal fish consumption, including the Seychelles Child Development Study, which Thurston serves on as an investigator.
The study was funded by the National Institute of Environmental Health Sciences/National Institutes of Health (NIEHS/NIH) grant numbers P42ES005947, R01ES014864, P30ES000002, and P30ES001247.
“A Novel Approach to Assessing the Joint Effects of Mercury and Fish Consumption on Neurodevelopment in the New Bedford Cohort,” Sally W. Thurston, David Ruppert, Susan A. Korrick, American Journal of Epidemiology, June 28, 2024, doi: 10.1093/aje/kwae149
Visit the Harvard Chan School website for the latest news, press releases, and multimedia offerings.
Image: iStock/Olesia Shadrina
For more information:
Maya Brownstein
mbrownstein@hsph.harvard.edu
Serena Bronda
sbronda@mgb.org
Mark Michaud
mark_michaud@urmc@rochester.edu
###
Harvard T.H. Chan School of Public Health brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. As a community of leading scientists, educators, and students, we work together to take innovative ideas from the laboratory to people’s lives—not only making scientific breakthroughs, but also working to change individual behaviors, public policies, and health care practices. Each year, more than 400 faculty members at Harvard Chan School teach 1,000-plus full-time students from around the world and train thousands more through online and executive education courses. Founded in 1913 as the Harvard-MIT School of Health Officers, the School is recognized as America’s oldest professional training program in public health.
Brigham and Women’s Hospital is a founding member of Mass General Brigham and a teaching affiliate of Harvard Medical School. With nearly 1,000 inpatient beds, approximately 50,000 inpatient stays, and over 2.6 million outpatient encounters annually, clinicians across the Brigham provide compassionate, high-quality care in virtually every medical and surgical specialty to patients locally, regionally, nationally and around the world. An international leader in basic, clinical, and translational research, Brigham and Women’s Hospital has nearly 5,000 scientists, including physician-investigators, renowned biomedical researchers and faculty supported by nearly $750 million in funding. The Brigham’s medical preeminence and service to the community dates to 1832, with the opening of the Boston Lying In, one of the nation’s first maternity hospitals designed to care for women unable to afford in-home medical care. Its merger with the Free Hospital for Women resulted in the Boston Hospital for Women in 1966. In 1980, the Boston Hospital for Women, the Peter Bent Brigham Hospital and the Robert Breck Brigham Hospital officially merged to become Brigham and Women’s Hospital. With nearly 21,000 employees across the Brigham family—including the Brigham and Women’s Physicians Organization and Brigham and Women’s Faulkner Hospital—that rich history is the foundation for our commitment to providing superb care for some of the most complex cases, pursuing breakthroughs in biomedical research, training the next generation of health care providers, and serving the local and global community.
One of the nation’s leading academic medical centers, URMC—comprised of Strong Memorial Hospital, Eastman Institute for Oral Health, the University of Rochester School of Medicine and Dentistry and its faculty practice (University of Rochester Medical Faculty Group), and the University of Rochester School of Nursing—forms the centerpiece of the University of Rochester’s health research, teaching and patient care missions. Under the UR Medicine clinical brand, URMC serves as upstate New York’s premier health care delivery network, anchored by Strong Memorial, an 886-bed, University-owned teaching hospital designated by the New York State Department of Health as a Level One Regional Trauma and Burn Center and home to Western New York’s only cardiac transplant program. With more than 28,000 part- and full-time employees, the Medical Center is the largest single component of the Rochester region’s leading employer.